Home Cart Sign in  
Chemical Structure| 3026500-20-6 Chemical Structure| 3026500-20-6

Structure of VVD-214
CAS No.: 3026500-20-6

Chemical Structure| 3026500-20-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

VVD-214 (also known as RO7589831) is a lethal allosteric inhibitor targeting WRN, showing potential antitumor activity.

Synonyms: RO7589831; VVD-133214

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of VVD-214

CAS No. :3026500-20-6
Formula : C20H21F2N3O4S
M.W : 437.46
SMILES Code : CS(/C=C/[C@H](C1CC1)NC(C(C(OC2=CC=CC=C2)=N3)=CN=C3C(F)(F)C)=O)(=O)=O
Synonyms :
RO7589831; VVD-133214
MDL No. :N/A

Safety of VVD-214

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HCT-116 cells 0.066 μM (IC50) 5 days To assess the antiproliferative effect of VVD-133214 in MSI-H HCT-116 cells. Results showed that VVD-133214 decreased cell growth and was blocked by the introduction of a drug-resistant C727A WRN mutant. PMID: 38658751
SW480 cells >20 μM 5 days To assess the antiproliferative effect of VVD-133214 in MSS SW480 cells. Results showed that VVD-133214 did not impair cell growth in MSS SW480 cells. PMID: 38658751

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Foxn1 mice HCT-116 xenograft Oral 2.5, 5, 10, 20 mg/kg Once daily for 3 weeks To assess the antitumor activity of VVD-133214 in HCT-116 xenograft models. Results showed that VVD-133214 caused dose-dependent tumor growth inhibition and regression in HCT-116 xenografts. PMID: 38658751

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.29mL

0.46mL

0.23mL

11.43mL

2.29mL

1.14mL

22.86mL

4.57mL

2.29mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records